Christopher Reilly-Stitt Selected Research

Christopher Reilly-Stitt Research Topics

5	Thrombosis (Thrombus) 01/2022 - 12/2013
4	Hemorrhage 08/2021 - 12/2013
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2021
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 01/2021
1	COVID-19 01/2021
1	Tics (Tic) 12/2020
1	Congenital Heart Defects (Congenital Heart Defect) 08/2013

3	Fibrinogen (Factor I)FDA Link 08/2021 - 08/2013
2	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 01/2021
2	Platelet Factor 4IBA 01/2022 - 01/2021
2	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2021
2	VaccinesIBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Thrombin FDA Link 04/2020 - 10/2016
2	Protein CIBA 04/2020 - 10/2016
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	von Willebrand FactorIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2020
1	TicagrelorIBA 12/2020
1	collagen-related peptideIBA 12/2020
1	thrombin receptor peptide (42-47)IBA 12/2020
1	Collagen ReceptorsIBA 12/2020
1	Glycoproteins (Glycoprotein)IBA 12/2020
1	ThrombomodulinIBA 10/2016
1	fibrinogen PerthIBA 12/2013
1	FibrinIBA 12/2013

1	Therapeutics 12/2020
1	Percutaneous Coronary Intervention 12/2020